Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
14%
ALSO IN GDOC
GDOC
39
HOLDINGS
11%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus GDOC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.9% | 9.7% | 9.7% |
|
ABBVIE INC | 8.8% | 6.4% | 6.4% |
|
MERCK & CO. INC. | 3.3% | 4.0% | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 5.4% | 1.7% | 1.7% |
MEDX Overweight Relative to GDOC
 |
NOVARTIS AG-ADR | 6.9% |
|
ELI LILLY & CO | 6.2% |
|
AMGEN INC | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.3% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% |
|
JOHNSON & JOHNSON | 4.7% |
 |
ALKERMES PLC | 4.2% |
|
PFIZER INC | 4.0% |
|
ALNYLAM PHARMACEUTICALS INC | 3.7% |
|
CRISPR THERAPEUTICS AG | 3.6% |
MEDX Underweight Relative to GDOC
|
BOSTON SCIENTIFIC CORP | -8.3% |
|
INTUITIVE SURGICAL INC | -5.8% |
|
ABBOTT LABORATORIES | -5.2% |
|
UNITEDHEALTH GROUP INC | -5.2% |
|
INSULET CORP | -4.4% |
|
ASTRAZENECA PLC | -4.2% |
|
COOPER COS INC/THE | -3.8% |
 |
NOVO NORDISK A/S-B | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.3% |
 |
CSL LIMITED | -3.1% |